Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Cheng Ma, Yin Cao, Guang Zhang, Jiannan Qiu, Yan Zhou, Peng Wang, Shuo Wang, Dongliang Yan, Ding Ma, Chunping Jiang & Zhongxia Wang. (2023) Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy. Journal of Hepatocellular Carcinoma 10, pages 217-230.
Read now
Read now
Heba Ahmed Osman, Hanaa Nafady-Hego, Khalid Ali Nasif, Heba A Ahmed, Ekram Abdel-Rahman Mahmoud, Noher Mohamad Abass, Amal Rayan, Marwa Ahmed Mahmoud & Asmaa Nafady. (2023) Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP. International Journal of General Medicine 16, pages 1047-1058.
Read now
Read now
Youwei Wu, Wei Peng, Junyi Shen, Xiaoyun Zhang, Chuan Li & Tian-fu Wen. (2023) Prognostic nomograms for HBV-related BCLC 0-a stage hepatocellular carcinoma incorporating aspartate aminotransferase to albumin ratio. Scandinavian Journal of Gastroenterology 58:7, pages 789-797.
Read now
Read now
Hao Xu, Chen Xiong, Yuan Chen, Chi Zhang & Dousheng Bai. (2021) Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Bioengineered 12:1, pages 2664-2675.
Read now
Read now
Articles from other publishers (52)
Huidan Yu, Lanhui Tan, Bing Xue, Ling Feng, Pei Fang, Xianmei Meng & Xianwu Luo. (2023) Platelet-to-lymphocyte, neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios are related to cancer-related fatigue and quality of life in patients with cancer: a cross-sectional study. BMJ Open 13:12, pages e075398.
Crossref
Crossref
Qian Wu, Pei Wang, Qihang Peng, Zhongcui Kang, Yiting Deng, Jiayi Li, Ying Chen, Jin Li & Feng Ge. (2023) Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker. International Journal of Molecular Sciences 24:23, pages 16986.
Crossref
Crossref
Lianjie Wang, Hui Geng, Yujie Liu, Lei Liu, Yanhua Chen, Fanchen Wu, Zhiyi Liu, Shiliang Ling, Yan Wang & Lihong Zhou. (2023) Hot and cold tumors: Immunological features and the therapeutic strategies. MedComm 4:5.
Crossref
Crossref
Aswathy R. Devan, Bhagyalakshmi Nair, Manu Kanjoormana Aryan, Vijayastelar B. Liju, Joel Joy Koshy, Bijo Mathew, Arun Valsan, Hoon Kim & Lekshmi R. Nath. (2023) Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence. Cancers 15:10, pages 2729.
Crossref
Crossref
Fei Cheng, Lebin Yuan, Zhao Wu, Huizi Li & Wei Shen. (2023) NIFK, an independent prognostic biomarker of hepatocellular carcinoma, is correlated with immune infiltration. Electronic Journal of Biotechnology 63, pages 30-40.
Crossref
Crossref
Ruonan Sun, Jiawei Li, Xianyi Lin, Yidong Yang, Bing Liu, Tianbi Lan, Shuang Xiao, Anyi Deng, Zhinan Yin, Yan Xu, Zheng Xiang & Bin Wu. (2023) Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Crossref
ZiHao Ni, BoLin Wu, Zhao Liu, QiuCheng Wang, Xue Han, Wen Cheng & CunLi Guo. (2023) Clinical value of combined preoperative–postoperative neutrophil-to-lymphocyte ratio in predicting hepatocellular carcinoma prognosis after radiofrequency ablation. The British Journal of Radiology 96:1145.
Crossref
Crossref
Maria Papanastasatou & Mihalis Verykokakis. (2023) Innate-like T lymphocytes in chronic liver disease. Frontiers in Immunology 14.
Crossref
Crossref
Esraa Ali, Andriy Trailin, Filip Ambrozkiewicz, Václav Liška & Kari Hemminki. (2022) Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. International Journal of Molecular Sciences 23:23, pages 15292.
Crossref
Crossref
Zhuo Yu, Jianfeng Guo, Yun Liu, Menglin Wang, Zhengsheng Liu, Yueqiu Gao & Leaf Huang. (2022) Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Konstantinos Arvanitakis, Triantafyllia Koletsa, Ioannis Mitroulis & Georgios Germanidis. (2022) Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy. Cancers 14:1, pages 226.
Crossref
Crossref
Haichuan Wang, Yu Zhang, Li Yan, Qiang Lv, Jie Lu & Bei Yun. (2022) Analysis of TRIM27 prognosis value and immune infiltrates in hepatocellular carcinoma. International Journal of Immunopathology and Pharmacology 36, pages 039463202211329.
Crossref
Crossref
Joseph W. Franses, Irun Bhan, Amaya Pankaj, David T. Ting, Vikram Deshpande & Kenneth Tanabe. (2021) Spontaneous Immune-Mediated Regression of Hepatocellular Carcinoma With High Tumor Mutational Burden. JCO Precision Oncology:5, pages 1040-1043.
Crossref
Crossref
Rongqiang Liu, Weihao Kong, ZeKun Jiang, Shiyang Zheng, Xiaofeng Yuan & Linsen Ye. (2021) ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma. Journal of Oncology 2021, pages 1-12.
Crossref
Crossref
Ningtao Cheng, Dajing Chen, Bin Lou, Jing Fu & Hongyang Wang. (2021) A biosensing method for the direct serological detection of liver diseases by integrating a SERS-based sensor and a CNN classifier. Biosensors and Bioelectronics 186, pages 113246.
Crossref
Crossref
Taosheng Huang, Huanqian Zhang, Yunzheng Zhao, Yanping Li, Guofeng Wang, Yunbo Zhang, Dong Guo, Shengjun Ji & Zhenyou Sun. (2021) Systemic immune-inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy. Future Oncology 17:17, pages 2141-2149.
Crossref
Crossref
Isabella Lurje, Wiebke Werner, Raphael Mohr, Christoph Roderburg, Frank Tacke & Linda Hammerich. (2021) In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma. Frontiers in Immunology 12.
Crossref
Crossref
Qian Yan, Wenjiang Zheng, Boqing Wang, Baoqian Ye, Huiyan Luo, Xinqian Yang, Ping Zhang & Xiongwen Wang. (2021) A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma. BioData Mining 14:1.
Crossref
Crossref
Yutao Yuan, Fangnian Yang, Yuanyuan Wang & Yusong Guo. (2021) Factors associated with liver cancer prognosis after hepatectomy. Medicine 100:42, pages e27378.
Crossref
Crossref
Matthias Bartneck, Christiane Koppe, Viktor Fech, Klaudia T. Warzecha, Marlene Kohlhepp, Sebastian Huss, Ralf Weiskirchen, Christian Trautwein, Tom Luedde & Frank Tacke. (2021) Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion. Cellular and Molecular Gastroenterology and Hepatology 11:2, pages 327-347.
Crossref
Crossref
Linlin Yang, Jessica A Jiménez, Alison M Earley, Victoria Hamlin, Victoria Kwon, Cameron T Dixon & Celia E Shiau. (2020) Drainage of inflammatory macromolecules from the brain to periphery targets the liver for macrophage infiltration. eLife 9.
Crossref
Crossref
Kumar Jayant, Nagy Habib, Kai W. Huang, Jane Warwick & Ramesh Arasaradnam. (2020) Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma. Diagnostics 10:5, pages 338.
Crossref
Crossref
Yanan Zhao, Kang Li, Jianping Sun, Ning He, Peng Zhao, Chaoran Zang, Xiaozhen Yang, Caixia Hu, Jiang Long, Honghai Zhang, Qi Wang, Yan Zhao & Yonghong Zhang. (2020) Genomic DNA methylation profiling indicates immune response following thermal ablation treatment for HBV‑associated hepatocellular carcinoma. Oncology Letters 20:1, pages 677-684.
Crossref
Crossref
Peirong Cai, Hao Zheng, Jinjin She, Nannan Feng, Hui Zou, Jianhong Gu, Yan Yuan, Xuezhong Liu, Zongping Liu & Jianchun Bian. (2020) Molecular Mechanism of Aflatoxin-Induced Hepatocellular Carcinoma Derived from a Bioinformatics Analysis. Toxins 12:3, pages 203.
Crossref
Crossref
Nada Chaoul, Serena Mancarella, Luigi Lupo, Gianluigi Giannelli & Francesco Dituri. (2020) Impaired Anti-Tumor T cell Response in Hepatocellular Carcinoma. Cancers 12:3, pages 627.
Crossref
Crossref
Christoph Roderburg, Alexander Wree, Münevver Demir, Moritz Schmelzle & Frank Tacke. (2020) The role of the innate immune system in the development and treatment of hepatocellular carcinoma. Hepatic Oncology 7:1.
Crossref
Crossref
Linsen Ye, Yang Li, Hui Tang, Wei Liu, Yunhao Chen, Tianxing Dai, Rongpu Liang, Mengchen Shi, Shuhong Yi, Guihua Chen & Yang Yang. (2019) CD8+CXCR5+T cells infiltrating hepatocellular carcinomas are activated and predictive of a better prognosis. Aging 11:20, pages 8879-8891.
Crossref
Crossref
Pao-Yuan Huang, Chih-Chi Wang, Chih-Che Lin, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Kwong-Ming Kee, Chien-Hung Chen, Kuang-Den Chen, Tsung-Hui Hu & Ming-Chao Tsai. (2019) Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy. Journal of Clinical Medicine 8:10, pages 1676.
Crossref
Crossref
Yi-Wen Hsiao, Lu-Ting Chiu, Ching-Hsuan Chen, Wei-Liang Shih & Tzu-Pin Lu. (2019) Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas. Genes 10:8, pages 630.
Crossref
Crossref
Adrien Guillot & Frank Tacke. (2019) Liver Macrophages: Old Dogmas and New Insights. Hepatology Communications 3:6, pages 730-743.
Crossref
Crossref
Jana C. Mossanen, Marlene Kohlhepp, Alexander Wehr, Oliver Krenkel, Anke Liepelt, Anjali A. Roeth, Diana Möckel, Felix Heymann, Twan Lammers, Nikolaus Gassler, Juliane Hermann, Joachim Jankowski, Ulf P. Neumann, Tom Luedde, Christian Trautwein & Frank Tacke. (2019) CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell–Dependent Control of Senescence. Gastroenterology 156:6, pages 1877-1889.e4.
Crossref
Crossref
James M. Henderson, Natasa Polak, Jinbiao Chen, Ben Roediger, Wolfgang Weninger, James G. Kench, Geoffrey W. McCaughan, Hui Emma Zhang & Mark D. Gorrell. (2018) Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma. Scientific Reports 8:1.
Crossref
Crossref
Rui Liao, Cong Peng, Ming Li, De-Wei Li, Ning Jiang, Pei-Zhi Li, Xiong Ding, Qiao Wu, Cheng-You Du & Jian-Ping Gong. (2018) Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy. Cancer Medicine 7:4, pages 1170-1182.
Crossref
Crossref
Liancheng Fan, Rui Wang, Chenfei Chi, Wen Cai, Yong Zhang, Hongyang Qian, Xiaoguang Shao, Yanqing Wang, Fan Xu, Jiahua Pan, Yinjie Zhu, Xun Shangguan, Lixin Zhou, Baijun Dong & Wei Xue. (2018) Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients. The Prostate 78:4, pages 250-256.
Crossref
Crossref
Pengpeng Zhu, Yan Liao, Jiyuan Fan, Xin Li, Lili Su, Jun Li, Shengguang Yuan, Junxiong Yu & Weijia Liao. (2017) Preoperative prediction of hepatocellular carcinoma with portal vein tumor thrombus based on conventional data. Oncotarget 8:61, pages 104227-104237.
Crossref
Crossref
Lu Wang, Cong Wang, Jiangfeng Wang, Xiaochen Huang & Yufeng Cheng. (2017) A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology 143:10, pages 2077-2086.
Crossref
Crossref
Shuo Pang, Ziquan Zhou, Xingchen Yu, Shaozhong Wei, Qiongrong Chen, Shaofa Nie, Xinjun Liang & Li Liu. (2017) The predictive value of integrated inflammation scores in the survival of patients with resected hepatocellular carcinoma: A Retrospective Cohort Study. International Journal of Surgery 42, pages 170-177.
Crossref
Crossref
Oliver Krenkel & Frank Tacke. (2017) Liver macrophages in tissue homeostasis and disease. Nature Reviews Immunology 17:5, pages 306-321.
Crossref
Crossref
Matthias Bartneck & Frank Tacke. 2017. The Immune Response to Implanted Materials and Devices. The Immune Response to Implanted Materials and Devices
213
222
.
Bei-li Wang, Lu Tian, Xing-Hui Gao, Xiao-Lu Ma, Jiong Wu, Chun-Yan Zhang, Yan Zhou, Wei Guo & Xin-Rong Yang. (2016) Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection. Clinical Chemistry and Laboratory Medicine (CCLM) 54:12, pages 1963-1969.
Crossref
Crossref
Cheng-Wei Li, Ping-Yao Chang & Bor-Sen Chen. (2016) Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method. Oncotarget 7:48, pages 79453-79473.
Crossref
Crossref
Andrea Casadei Gardini, Emanuela Scarpi, Luca Faloppi, Mario Scartozzi, Nicola Silvestris, Daniele Santini, Giorgio de Stefano, Giorgia Marisi, Francesca V. Negri, Francesco Giuseppe Foschi, Martina Valgiusti, Giorgio Ercolani & Giovanni Luca Frassineti. (2016) Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib. Oncotarget 7:41, pages 67142-67149.
Crossref
Crossref
Josef Ehling & Frank Tacke. (2016) Role of chemokine pathways in hepatobiliary cancer. Cancer Letters 379:2, pages 173-183.
Crossref
Crossref
Ji-Yong Song, Guo-Sheng Du, Li Xiao, Wen Chen, Long-Long Suo, Yu Gao, Li-Kui Feng & Bing-Yi Shi. (2016) Individualized Immunosuppressive Protocol of Liver Transplant Recipient Should be Made Based on Splenic Function Status. Chinese Medical Journal 129:11, pages 1340-1346.
Crossref
Crossref
Matthias Bartneck, Viktor Fech, Josef Ehling, Olivier Govaere, Klaudia Theresa Warzecha, Kanishka Hittatiya, Mihael Vucur, Jérémie Gautheron, Tom Luedde, Christian Trautwein, Twan Lammers, Tania Roskams, Willi Jahnen‐Dechent & Frank Tacke. (2016) Histidine‐rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease. Hepatology 63:4, pages 1310-1324.
Crossref
Crossref
Felix Heymann & Frank Tacke. (2016) Immunology in the liver — from homeostasis to disease. Nature Reviews Gastroenterology & Hepatology 13:2, pages 88-110.
Crossref
Crossref
Zongguo Yang, Jianliang Zhang, Yunfei Lu, Qingnian Xu, Bozong Tang, Qiang Wang, Wensi Zhang, Shishi Chen, Lingqing Lu & Xiaorong Chen. (2015) Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization. Oncotarget 6:40, pages 43090-43098.
Crossref
Crossref
Alexander Wehr & Frank Tacke. (2015) The Roles of CXCL16 and CXCR6 in Liver Inflammation and Fibrosis. Current Pathobiology Reports 3:4, pages 283-290.
Crossref
Crossref
Keishi Sugimachi, Shotaro Sakimura, Akira Tomokuni, Ryutaro Uchi, Hidenari Hirata, Hisateru Komatsu, Yoshiaki Shinden, Tomohiro Iguchi, Hidetoshi Eguchi, Takaaki Masuda, Kazutoyo Morita, Ken Shirabe, Hidetoshi Eguchi, Yoshihiko Maehara, Masaki Mori & Koshi Mimori. (2015) Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients. Journal of Clinical Medicine 4:8, pages 1600-1611.
Crossref
Crossref
Junfei Jin, Pengpeng Zhu, Yan Liao, Jun Li, Weijia Liao & Songqing He. (2015) Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection. Oncotarget 6:22, pages 19217-19227.
Crossref
Crossref
Swati Joshi-Barve, Irina Kirpich, Matthew C. Cave, Luis S. Marsano & Craig J. McClain. (2015) Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences. Cellular and Molecular Gastroenterology and Hepatology 1:4, pages 356-367.
Crossref
Crossref
Yiqiong Jia, Zhen Zeng, Yuanyuan Li, Zhiwei Li, Lei Jin, Zheng Zhang, Lifeng Wang & Fu-Sheng Wang. (2015) Impaired Function of CD4+ T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma Progression. PLOS ONE 10:2, pages e0117458.
Crossref
Crossref